Community Program For Clinical Research on AIDS

> Home
> About the CPCRA
> Our Science Agenda
> Publications & Presentations

> The CPCRA Network
> CPCRA Units
> Community Involvement
> CPCRA News

> Member Information
> Group Meeting
> Online Directory
> Contact Us

some of the many faces that make up the CPCRA


2006 Posters and Presentations









Integrating HIV Research Into Primary Care


  • Summary of 2006 CPCRA Posters and Presentations 03/07
  • 10th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI), October 2006, Bethesda, Maryland

  • Abrams D, Risk of cancers during interrupted antiretroviral therapy: malignant outcomes in the SMART study
    abstract ! poster ! slides

  • XVI International AIDS Conference, August 13-18, 2006, Toronto, Canada

  • Burman W. The effect of episodic CD4-guided antiretroviral therapy on quality of life: results of the Quality of Life substudy of SMART. Poster. Abstract number: THPE0145.
    abstract

  • Cohn D. Severity and types of clinical events by proximal CD4 cell counts in the SMART study. Poster. Abstract number: THPE0047
    abstract


  • El-Sadr W. Inferior Clinical Outcomes with Episodic CD4-guided Antiretroviral Therapy Aimed at Drug Conservation (DC) in SMART Study: Consistency of Finding in All Patient Subgroups. Oral.
    abstract


  • Gibert CL, Shlay JC, Bartsch G3, Peng G, Wang J, Visnergarwala F, Raghavan S, Xiang Y, Farrough M, Perry HE, Grunfeld C, El-Sadr WM. Long-term changes in body composition among HIV-infected antiretroviral naïve persons randomized to PI vs. NNRTI vs. PI + NNRTI-based antiretroviral regimens: Results of the CPCRA 061 metabolic Study. Poster. Abstract number: WEPE0143.
    abstract


  • Grund B. Predictors for the initial CD4 decline after antiretroviral treatment interruption in the SMART study. Poster.
    abstract


  • MacArthur RD, Novak RM, Peng G, Chen L, Xiang Y, Kozal MJ, van den Berg-Wolf M, Henely C, Huppler-Hullsiek K, Schmetter B, Dehlinger M. Long-Term Clinical and Immunologic Outcomes Are Similar in HIV-Infected Persons Randomized to NNRTI vs PI vs NNRTI+PI-based Antiretroviral Regimens as Initial Therapy: Results of the CPCRA 058 FIRST Study. Oral. Abstract number: TUAB0102.
    abstract


  • Lundgren JD. Progression of HIV-related disease or death (POD) in the randomised SMART study: why was the risk of POD greater in the CD4-guided ((re)-initiate ART at CD4 < 250 cells/µL) drug conservation (DC) vs the virological suppression (VS) arm ? Oral.
    abstract


  • Shlay JC, Bartsch G, Peng G, Wang J, Gibert C, Visnegarwala F, Raghavan SS, Xiang Y, Farrough M, Perry HE, Kotler D, Grunfeld C, El-Sadr WM. Long-Term Changes in Lipids and Glucose/Insulin LevelsMetabolic and Body Composition Changes Among HIV-Infected Antiretroviral Naïve Persons Randomized to PI vs. NNRTI vs. PI + NNRTI-Based Antiretroviral Regimens: Results of the CPCRA 061 Metabolic Study. Oral. Abstract number: THAB0101.
    abstract


  • van den Berg-Wolf M, Peng G, Xiang Y, Huppler Hullsiek K, Chen L, MacArthur RD, Novak RM, Kozal M, Schmetter B, Henely C, Dehlinger M. Efficacy and Safety of Nevirapine versus efavirenz When Combined in ART Regimens in HIV Infected antiretroviral-Naïve Persons (The NNRTI Substudy of FIRST-CPCRA 058). Poster. Abstract number: THPE0104
    abstract

    XV International HIV Drug Resistance Workshop, June 13-17, 2006, Sitges, Spain

  • Kozal MJ, Huppler Hullsiek K, MacArthur RD, Peng G, Xiang Y, Baxter JD, Van den Berg-Wolf M. Initial Virologic Failure with HIV Drug Resistance and Impact of Resistance on Disease Progression and Death for Patients Beginning PI, NNRTI or PI+NNRTI Based Strategies: The FIRST Study. Oral.
    pdf


    NIMH/IAPAC International Conference on HIV Treatment Adherence, March 8-10, 2006, Jersey City, NJ.

  • Mannheimer S, Thackeray L, Huppler Hullsiek K, Chesney M, Gardner E, Wu A, Telzak E, Lawrence J, Baxter J, Friedland G. A Randomized Comparison of Two Instruments for Assessing Self-Reported Antiretroviral Adherence.
    abstract


    13th Conference on Retroviruses and Opportunistic Infections, February 5-9, 2006, Denver, CO

  • Carr A, ART and asymptomatic ischemic heart disease in HIV-infected adults: A cross-sectional analysis of patients enrolling in the SMART trial. abstract ! poster

  • El-Sadr W, Neaton J. SMART Study Presentation. pdf

  • Lawrence J, Huppler Hullsiek K, Coakley E, Bates M, Weidler J, Lie Y, Pesano R, Thackeray L, Baxter J. Antiretroviral Phenotypic Susceptibility Score as a Predictor of Treatment Response in Persons with Multidrug-Resistant HIV-1.
    abstract

  • Brar I, Shuter J, Wentworth D, Thomas A, Daniels E, Absalon J. Comparison of Diabetes Mellitus Prevalence and Risk Factors among HIV-Infected Antiretroviral (ART) Naïve Individuals versus Individuals in the National Health and Nutritional Examination Survey (NHANES) III Cohort.
    abstract